The actual approach of sentinel node biopsy in cutaneous melanoma

Sentinel lymph node biopsy (SLNB) is a well-established standard of care in melanoma treatment, but its role is evolving.Before the advent of modern systemic therapies, SLNB was critical in identifying which patients would benefit fromcomplementary lymphadenectomy and which would not require this pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Szymaniak, Julia A. Janecka, Wiktor Grabek, Jan Radomski, Kinga Flisiewicz-Wysocka, Karolina Mizera, Mateusz Wichtowski
Format: Article
Language:English
Published: Via Medica 2025-01-01
Series:Nowotwory
Subjects:
Online Access:https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/view/104831
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849231169702330368
author Maria Szymaniak
Julia A. Janecka
Wiktor Grabek
Jan Radomski
Kinga Flisiewicz-Wysocka
Karolina Mizera
Mateusz Wichtowski
author_facet Maria Szymaniak
Julia A. Janecka
Wiktor Grabek
Jan Radomski
Kinga Flisiewicz-Wysocka
Karolina Mizera
Mateusz Wichtowski
author_sort Maria Szymaniak
collection DOAJ
description Sentinel lymph node biopsy (SLNB) is a well-established standard of care in melanoma treatment, but its role is evolving.Before the advent of modern systemic therapies, SLNB was critical in identifying which patients would benefit fromcomplementary lymphadenectomy and which would not require this procedure. Currently, after a positive sentinel node biopsy, lymphadenectomy is no longer performed, altering the procedure’ssignificance. The SLNB identifies patients who will benefit from adjuvant treatment. Additionally, it enhances controlover locoregional lymphatic flow. As for now, there is no alternative to sentinel node biopsy. The gold standard for marking sentinel nodes in melanoma remains the dual radioisotope-dye method, using lymphoscintigraphyand SPECT-CT. There is ongoing research for new tracers that might replace this method, likely ferromagnetic tracers, which have shownnon-inferiority in breast cancer, have not yet proven to be of comparable value in melanoma, due to unpredictablelymphatic drainage, which required preoperative imaging.
format Article
id doaj-art-b9c40c55124545b2b09ccd05e0b64d26
institution Kabale University
issn 0029-540X
2300-2115
language English
publishDate 2025-01-01
publisher Via Medica
record_format Article
series Nowotwory
spelling doaj-art-b9c40c55124545b2b09ccd05e0b64d262025-08-21T05:43:35ZengVia MedicaNowotwory0029-540X2300-21152025-01-0175310.5603/njo.104831The actual approach of sentinel node biopsy in cutaneous melanomaMaria Szymaniak0https://orcid.org/0009-0009-6497-7527Julia A. Janecka1https://orcid.org/0009-0005-9011-817XWiktor Grabek2https://orcid.org/0000-0002-9968-1955Jan Radomski3https://orcid.org/0000-0002-5931-7032Kinga Flisiewicz-Wysocka4https://orcid.org/0009-0004-5623-3871Karolina Mizera5https://orcid.org/0009-0000-7797-6333Mateusz Wichtowski6https://orcid.org/0000-0002-8507-2550Surgical Oncology Clinic, Institute of Oncology, Poznan University of Medical Sciences, PolandSurgical Oncology Clinic, Institute of Oncology, Poznan University of Medical Sciences, PolandSurgical Oncology Clinic, Institute of Oncology, Poznan University of Medical Sciences, PolandSurgical Oncology Clinic, Institute of Oncology, Poznan University of Medical Sciences, PolandSurgical Oncology Clinic, Institute of Oncology, Poznan University of Medical Sciences, PolandSurgical Oncology Clinic, Institute of Oncology, Poznan University of Medical Sciences, PolandSurgical Oncology Clinic, Institute of Oncology, Poznan University of Medical Sciences, PolandSentinel lymph node biopsy (SLNB) is a well-established standard of care in melanoma treatment, but its role is evolving.Before the advent of modern systemic therapies, SLNB was critical in identifying which patients would benefit fromcomplementary lymphadenectomy and which would not require this procedure. Currently, after a positive sentinel node biopsy, lymphadenectomy is no longer performed, altering the procedure’ssignificance. The SLNB identifies patients who will benefit from adjuvant treatment. Additionally, it enhances controlover locoregional lymphatic flow. As for now, there is no alternative to sentinel node biopsy. The gold standard for marking sentinel nodes in melanoma remains the dual radioisotope-dye method, using lymphoscintigraphyand SPECT-CT. There is ongoing research for new tracers that might replace this method, likely ferromagnetic tracers, which have shownnon-inferiority in breast cancer, have not yet proven to be of comparable value in melanoma, due to unpredictablelymphatic drainage, which required preoperative imaging.https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/view/104831sentinel node biopsytracersferromagneticradioisotope
spellingShingle Maria Szymaniak
Julia A. Janecka
Wiktor Grabek
Jan Radomski
Kinga Flisiewicz-Wysocka
Karolina Mizera
Mateusz Wichtowski
The actual approach of sentinel node biopsy in cutaneous melanoma
Nowotwory
sentinel node biopsy
tracers
ferromagnetic
radioisotope
title The actual approach of sentinel node biopsy in cutaneous melanoma
title_full The actual approach of sentinel node biopsy in cutaneous melanoma
title_fullStr The actual approach of sentinel node biopsy in cutaneous melanoma
title_full_unstemmed The actual approach of sentinel node biopsy in cutaneous melanoma
title_short The actual approach of sentinel node biopsy in cutaneous melanoma
title_sort actual approach of sentinel node biopsy in cutaneous melanoma
topic sentinel node biopsy
tracers
ferromagnetic
radioisotope
url https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/view/104831
work_keys_str_mv AT mariaszymaniak theactualapproachofsentinelnodebiopsyincutaneousmelanoma
AT juliaajanecka theactualapproachofsentinelnodebiopsyincutaneousmelanoma
AT wiktorgrabek theactualapproachofsentinelnodebiopsyincutaneousmelanoma
AT janradomski theactualapproachofsentinelnodebiopsyincutaneousmelanoma
AT kingaflisiewiczwysocka theactualapproachofsentinelnodebiopsyincutaneousmelanoma
AT karolinamizera theactualapproachofsentinelnodebiopsyincutaneousmelanoma
AT mateuszwichtowski theactualapproachofsentinelnodebiopsyincutaneousmelanoma
AT mariaszymaniak actualapproachofsentinelnodebiopsyincutaneousmelanoma
AT juliaajanecka actualapproachofsentinelnodebiopsyincutaneousmelanoma
AT wiktorgrabek actualapproachofsentinelnodebiopsyincutaneousmelanoma
AT janradomski actualapproachofsentinelnodebiopsyincutaneousmelanoma
AT kingaflisiewiczwysocka actualapproachofsentinelnodebiopsyincutaneousmelanoma
AT karolinamizera actualapproachofsentinelnodebiopsyincutaneousmelanoma
AT mateuszwichtowski actualapproachofsentinelnodebiopsyincutaneousmelanoma